60 likes | 70 Views
Global Market Insights add New Report Global Digital Diabetes Management Market to its research database. The report focuses on global major leading players with information such as company profiles, Growth, product segment, technology segment, end user segment and region.
E N D
Digital Diabetes Management Market SWOT Analysis of Top Key Player & Forecasts To 2030 © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
Market Scenario of Digital Diabetes Management Market • Global Market Insights adds a new report Global Digital Diabetes Management Market Research Report for the period of 2022-2030 that shows the growth of the market is rising at a Steady CAGR to 2030. • Strategic partnerships among leading players in the space of diabetes treatment and diagnosis is expected to consolidate growth of the market further. In 2021, French medical devices firm, BIOCORP, collaborated with world-leading diabetes care provider, Novo Nordisk, over smart insulin pens. • The collaboration aimed at developing and distributing Mallya smart add-on device, which is a Bluetooth-enabled smart device for pen injectors such as Novo Nordisk FlexTouch pen that is commonly used by diabetic patients. • The global digital diabetes management market is bifurcated into product type, patient type, end-use, and region. © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
Continue:- • Based on product type, the digital diabetes management industry is divided into services, devices, and device type. The device segment is further sectioned into smart CGM, smart insulin pens, smart blood glucose meters, and smart insulin pumps. The device type is bifurcated into wearable, handheld. Services product type segment is further sub-segmented into software and apps. • Among these, services product segment is estimated to grow at a CAGR of around 19.6% through the forecast timeline, driven by the development of advanced software and mobile applications that facilitate real time access to patient data. • Advantages such as continuous monitoring and management of large volumes of patient data will pave the way for segment growth. © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
360° Industry Analysis • With respect to patient type, the digital diabetes management market is categorized into type 1 diabetes, and type 2 diabetes. In 2021, the type 2 diabetes segment accounted for more than 90% of overall digital diabetes management market share. • Key driving factors that are fueling the segment growth include increasing type 2 diabetes patient pool, rapid adoption of digital technologies for better diabetes management and increasing preference for smart devices to monitor blood glucose and insulin dosage. • In terms of end-use, the digital diabetes management business is fragmented into home settings, hospitals, diagnostic centers & clinics, and others. In 2021, the digital diabetes management market generated over 16% of its total revenue share from diagnostic centers and clinics. • The segment saw such a scale of growth on account of fast-paced development of healthcare infrastructure. Increasing initiatives to enhance access to clinics across remote areas is likely to foster segment growth over the forecast period. © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
Competitive Analysis: • Abbott • Medtronic Plc • F.Hoffmann-LA Roche Ltd • Dexcom Inc • Senseonics • Insulet Corporation • Tandem Diabetes • Ypsomed • Ascensia Diabetes Care Holdings Ag • Tidepool • Glooko Inc. • DarioHealth Corporation • Novo Nordisk • Pendiq • Browse Complete Summary of this report @ https://www.gminsights.com/industry-analysis/digital-diabetes-management-market © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
Stay In Touch You can visit us at: www.gminsights.com Thank You…! © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com